Juan José Menéndez Suso

Juan José Menéndez Suso

Auto-generated profile, based on publicly available information

Juan José Menéndez Suso

Pediatric Critical Care Department, Hospital Universitario La Paz, Madrid, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2022 in Journal of Ultrasound in Medicine
Verified
Journal Article
Closed access
JMJuan J. Menéndez‐Suso
Juan J. Menéndez‐Suso
DRDiego Rodríguez‐Álvarez
Diego Rodríguez‐Álvarez
MSMaría Sánchez‐Martín
María Sánchez‐Martín

1 February 2023 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Closed access
PDF file
JMJuan José Menéndez
Juan José Menéndez
ASAmelia Caridad Sánchez-Galindo
Amelia Caridad Sánchez-Galindo
JBJoan Balcells
Joan Balcells
MTMaría Ángeles Tejero-Hernández
María Ángeles Tejero-Hernández
ÁFÁngela Ferrer-Barba
Ángela Ferrer-Barba
LGLuis Garcia-Gueretaa
Luis Garcia-Gueretaa
To describe the use of ventricular assist devices (VAD) in children in Spain and to identify variables related to survival. This is an observational cohort study of all children younger than 18 years of age who underwent an initial implantation of a VAD at any of the six paediatric heart transplant centers from May 2006 to December 2020. Subjects were identified retrospectively from each hospital's database. Paracorporeal VADs were implanted in 118 children (pulsatile [63%], continuous [30.5%] or both types [5.9%]). Small children (< 0.7 m2 of body surface area) comprised the majority of this cohort (63.3%). Overall, 67% survived to VAD explantation, and 64.9% survived to hospital discharge. Non-central nervous system haemorrhage (39%) and stroke (38.1%) were the most common complications. Body weight 34 μmol/L and bridge to decision strategy, were associated with a higher mortality at hospital discharge and in the long-term. Interagency registry for mechanically assisted circulatory support (INTERMACS) status 1 and cardiac arrest prior to VAD implantation were related to long-term mortality, whereas pre-implantation renal replacement therapy and extracorporeal membrane oxygenation were not related to mortality. In Spain, 67% of the VAD-supported children have been bridged to heart transplantation or to recovery. Body weight lower than 5 Kg, congenital heart disease diagnosis, cholestatic liver dysfunction, bridge to decision as VAD strategy, INTERMACS-1 status and cardiac arrest were pre-implantation variables related to mortality, whereas pre-implantation renal replacement therapy and extracorporeal membrane oxygenation were not.

18 July 2022 in Acute and Critical Care
Verified
Journal Article
Open access
PDF file
DÁDiego Rodríguez Álvarez
Diego Rodríguez Álvarez
EPElena Pérez-Costa
Elena Pérez-Costa
JSJuan José Menéndez Suso
Juan José Menéndez Suso

21 July 2025 in Anales de Pediatría
Verified
Journal Article
Open access
MMMarta Pacio Miguez
Marta Pacio Miguez
SGSixto García-Miñaúr
Sixto García-Miñaúr
ÁPÁngela del Pozo
Ángela del Pozo
JSJuan José Menéndez Suso
Juan José Menéndez Suso
FAFrancisco J. Climent Alcalá
Francisco J. Climent Alcalá
MBMaria Palomares Bralo
Maria Palomares Bralo